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Abstract: Guidelines recommend stepped and collaborative care models (SCM) for depression. We aimed
to evaluate the effectiveness of a complex guideline-based SCM for depressed patients. German primary
care units were cluster-randomised into intervention (IG) or control group (CG) (3:1 ratio). Adult routine
care patients with PHQ-9 ฀ 5 points could participate and received SCM in IG and treatment as usual
(TAU) in CG. Primary outcome was change in PHQ-9 from baseline to 12 months (hypothesis: greater
reduction in IG). A linear mixed model was calculated with group as fixed effect and practice as random
effect, controlling for baseline PHQ-9 (intention-to-treat). 36 primary care units were randomised to IG
and 13 to CG. 36 psychotherapists, 6 psychiatrists and 7 clinics participated in SCM. 737 patients were
included (IG: n = 569 vs. CG: n = 168); data were available for 60% (IG) and 64% (CG) after 12 months.
IG showed 2.4 points greater reduction [95% confidence interval (CI): -3.4 to -1.5, p < 0.001; Cohen’s
d = 0.45] (adjusted PHQ-9 mean change). Odds of response [odds ratio: 2.8; 95% CI: 1.6 to 4.7] and
remission [odds ratio: 3.2; 95% CI: 1.58 to 6.26] were higher in IG. Guideline-based SCM can improve
depression care.
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Abstract
In order to optimize patient allocation, guidelines recommend stepped and collaborative
care models (SCM) including low-intensity treatments. The aim of this study is to investigate
the implementation of guideline-adherent treatments in a SCM for depression in routine
care. We analyzed care provider documentation data of n = 569 patients treated within a
SCM. Rates of guideline-adherent treatment selections and initializations as well as accor-
dance between selected and initialized treatment were evaluated for patients with mild,
moderate and severe depression. Guideline-adherent treatment selection and initialization
was highest for mild depression (91% resp. 85%). For moderate depression, guideline-
adherent treatments were selected in 68% and applied in 54% of cases. Guideline adher-
ence was lowest for severe depression (59% resp. 19%). In a multiple mixed logistic regres-
sion model a significant interaction between guideline adherence in treatment selection/
initialization and severity degree was found. The differences between treatment selection
and initialization were significant for moderate (OR: 1.8 [95% CI: 1.30 to 2.59; p = 0.0006])
and severe depression (OR: 6.9; [95% CI: 4.24 to 11.25; p < .0001] but not for mild depres-
sion (OR = 1.8, [95%-CI: 0.68 to 4.56; p = 0.2426]). Accordance between selected and ini-
tialized treatment was highest for mild and lowest for severe depression. We conclude that
SCMs potentially improve care for mild depression and guideline adherence of treatment
selections. Guideline adherence of treatment initialization and accordance between treat-
ment selection and initialization varies with depression severity. Deficits in treating severe
depression adequately may be more a problem of failed treatment initializations than of
inadequate treatment selections.
Introduction
Depression is a widespread disease and causes severe impairments, a high degree of personal
suffering [1] and high direct and indirect costs [2]. Detailed estimations predict that the
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depression-related disease burden will increase in the next 20 years and that depression will
represent the most important factor for impairment in high income countries [1]. With a
1-year prevalence of 7.7%, unipolar depression is one of the most widespread mental diseases
in the European population [3, 4].
In order to provide effective care for depression, guidelines for evidence-based diagnosis
and treatment of unipolar depression have been developed worldwide [5–9]. Recommendations
include–among others–screening high-risk groups for depression, distinguishing between dif-
ferent severity levels, providing active monitoring, acute and maintenance therapy as well as
carefully assessing self-harm or suicide risk. Some of the recommendations are specific to the
disease course or certain patient groups (e.g. chronic course, patients with somatic comorbidi-
ties), while most of the treatment recommendations are related to depression severity [5, 6, 9]:
For first episodes of mild depression, guidelines recommend active monitoring. Other guide-
line-adherent treatments for mild depression comprise low-intensity treatments like bibliother-
apy, individual guided self-help based on cognitive-behavioral principles, computerized
cognitive-behavioral therapy, and structured physical activity programs, as well as psychothera-
peutic approaches. Treatment with psychotherapy or pharmacotherapy is recommended for
moderately depressed patients, while a combination of psycho- and pharmacotherapy should
be provided for severe depression. Next to the criterion of depression severity, guidelines rec-
ommend the explicit consideration of patient preferences regarding a shared decision.
While the development of guidelines represents an important improvement, the implemen-
tation of their evidence-based recommendations is still insufficient [10–21]. Depression often
remains undetected and is diagnosed with delay [22–25], and diagnoses are often unspecific:
For instance, analyses of German health insurance data show that 50% of all depression diag-
noses do not specify severity degrees according to the “International Statistical Classification
of Diseases and Related Health Problems—10”-Classification System (ICD-10) [26]; the
majority of these diagnoses were made by general practitioners (GPs) [14]. Partly as a conse-
quence of unspecific diagnostics, treatment selection is often also not specific and thus not in
accordance with the guideline: For instance, according to a British primary care study, GPs
prescribe antidepressants to 49% of patients with mild depression [27], although guidelines
recommend not using antidepressants routinely to treat mild depression due to their poor
risk-benefit ratio [5]. A general challenge is to actually apply and initiate adequate interven-
tions [28, 29]: A European study shows that only 23% of patients with depression or anxiety
disorders were provided an adequate treatment [11, 25] while in a Canadian survey only 30%
of patients with mood disorders received any treatment at all [30]. Finally, only 50% of patients
with moderate to severe depression or dysthymia received guideline-adherent interventions
(antidepressants, psychotherapy, or the combination of both) for a sufficiently long duration,
indicating high rates of undersupply [14].
Stepped care models as recommended by guidelines may optimize treatment decisions and
the provision of evidence-based treatments [31, 32] by allocating as many patients as possible
to low-intensity treatments, thus reserving more intensive interventions for patients in greater
need [33]. In fixed stepped care, all patients begin with low-intensity interventions and step up
if they do not benefit sufficiently. In stratified stepped care, patients are assigned to treatments
of different intensities from the start, taking into consideration patient characteristics as well
as initial symptom severity. Their treatment course is monitored regularly [33]. Studies
addressing the implementation of stepped care vary strongly regarding study population, care
model, and comparison groups [34]. Common optional elements are guided self-help, psy-
choeducation, antidepressant medication and psychological interventions such as cognitive
behavioral therapy (low- or high-intensity), brief psychotherapy, interpersonal therapy, moti-
vational interviewing and problem-solving therapy [34].
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A guideline-based stepped and collaborative care model (SCM) was implemented in rou-
tine care within the research project “Health Network Depression” as part of psychenet–the
Hamburg Network for Mental Health [35]. Its aim was the improvement of health care for
patients with depression by providing integrated and evidence-based health care according to
the German National Clinical Practice Guideline “Unipolar Depression” [32]. A specially
trained multi-professional network of GPs, psychotherapists, psychiatrists and in-patient facil-
ities was established. The aim of this network was to optimize diagnostic procedures, to
improve treatment selection interventions and thus enable an early detection of depression fol-
lowed by a prompt, professional and effective and efficient treatment. The SCM integrated var-
ious evidence-based treatment options of different intensities, including innovative low-
intensity interventions based on cognitive-behavioral methods. This is the first evaluation of
the systematic application of these interventions within a SCM in German routine care [36].
Against the background of insufficient guideline implementation [11, 12, 14, 15, 28] and
lack of knowledge about the reasons for this shortcoming, it is important to analyze which
treatments were selected at first place and whether they were actually initialized [18]. We
defined initially selected treatments as treatment recommendations given by the GP under
consideration of the preference and motivation of the patient, while we defined actually initial-
ized treatments as the first treatment a patient received in the SCM. This is also highly relevant
taking into consideration that the first intervention in a patient’s treatment pathway plays a
decisive role in the further care process [33].
The objective of this study was to investigate selection and initialization of first treatments
patients receive in a guideline-based SCM for depression in primary care. More specifically,
we aimed to investigate the following research questions:
1. How are treatment selection and treatment initialization implemented with regard to
guideline-adherence for patients with different severity levels of depression?
2. To what degree do selected and initialized treatments match?
Methods
Study design and setting
This study is part of a larger project evaluating the SCM’s effectiveness and cost-effectiveness
in a randomized controlled intervention trial of a consecutive sample of depressed patients
from primary care, with assessments at baseline and 3, 6 and 12 months after baseline [36].
Through cluster-randomization on the level of the participating primary care units, GPs were
divided into two groups: GPs in the intervention group treated patients within the SCM,
whereas GPs in the control group carried out treatment as usual (for details and results con-
cerning the main study see [36, 37]).
The analyses provided here refer solely to the intervention group, i.e. to the GPs applying
SCM and the patients receiving SCM. A comparable analysis between IG and CG referring to
the research described above was not possible to perform, as there is no data available on the
CG patients’ diagnoses nor on the treatments selected and initialized by the GPs in the CG
which is explained by the study design and main research question of the overall study. Within
a cross-sectional approach, we analyzed data documented by health care providers regarding
diagnostic procedures, treatment decisions and monitoring routines as well as data from ques-
tionnaires completed by patients at baseline and 3 months after baseline. Patient enrollment
took place from October 2012 to March 2014.
Ethical approval. The study was approved by the responsible local Ethics Committee of
the Chamber of Psychotherapists in Hamburg and conducted according to the principles of
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the Declaration of Helsinki (2013 version). The study protocol was registered under Clinical-
Trials.gov, NCT01731717.
Patient recruitment. Patient recruitment was carried out by the participating GPs and
comprised three guideline-recommended assessment steps supported by checklists [38]: First,
the GP systematically screened patients with particular risk factors for depression (presence of
diffuse somatic symptoms and/or chronic somatic conditions [32, 39]) by applying a 2-item
checklist. If screened positively, the GP assessed the main depression criteria (persistent low
mood and/or loss of interest or pleasure) with the 2-item depression screener [40]. If at least one
of two criteria was fulfilled, the patient was assessed with the depression module of the Patient
Health Questionnaire-9 (PHQ-9, [41]). The study’s inclusion criteria were a score of five or
more points on the PHQ-9, informed consent and a minimum age of 18 years. Patients with
insufficient knowledge of German or a health situation that did not allow study inclusion were
excluded, as well as patients already receiving psychotherapy or pharmacotherapy for a mental
disorder on the day of entering the study. Neither use of psychotherapy or pharmacotherapy in
the past during a prior episode nor somatic or mental comorbidities were exclusion criteria.
Stepped and collaborative care network
The stepped and collaborative care intervention implemented in our study is a complex inter-
vention consisting of several guideline-based components such as a multiprofessional network
trained in guideline-based diagnostics and treatment of depression, optimized diagnostic pro-
cedures, improved indication, specific evidence-based treatment options of different intensi-
ties (including innovative low-intensity interventions based on cognitive-behavioral methods),
standardized monitoring procedures, regular quality circles and an online platform[36].
A necessary framework to promote collaborative treatment in the SCM is a network con-
sisting of the relevant care providers involved in treating depressive patients, i.e. GPs, psycho-
therapists, psychiatrists, day care and inpatient care facilities [38, 42]. One of the network’s
main aims was to enhance cooperation and communication between network members to
increase quality of care. Another important aim was the prompt referral from the GP to sec-
ondary care, i.e. to a psychotherapist or psychiatrist. Both aims were supported by an online
platform specifically developed for the needs of the network in order to book available treat-
ment capacities in secondary care. To ensure that defined quality standards were met and to
promote cooperation and information exchange between participating care providers, quar-
ter-yearly quality circles took place [40, 43]. Additionally a network booklet with personal con-
tact data for use within the network was made available. Personal contact with another
network care provider in order to refer a jointly treated patient by phone or mail was rewarded
by incentives. Previous to the implementation of the SCM, participating care providers
obtained training regarding guideline recommendations for diagnostics and treatment [32],
rationale and concept of the SCM. Further incentives were given to the care providers for
every diagnostic and treatment activity that was not covered by routine care.
Diagnostic process and treatment selection. After screening patients, GPs continued the
diagnostic process by determining depression type and severity with a checklist of ICD-10
depression criteria (“ICD-10-checklist”). Patients were informed about depression and treat-
ment options. Treatment decisions were made following principles of shared decision-making
and documented on the “treatment decision checklist”. Treatments were allocated following a
stratified approach considering depression severity and patient preferences as recommended
by guidelines [5, 32].
Treatment options and guideline adherence. Patients were offered one of several treat-
ment options of different treatment intensities [36]. The definition which treatment option
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was guideline adherent for which type of depression is based on national and international
depression guidelines following the criteria of severity degree [5, 6]. The German guideline for
depression is similar to the NICE guideline for depression. One difference is that the German
guideline refers to depression definitions according to ICD-10 whereas the NICE guideline
and the Australian and New Zealand clinical practice guideline for the treatment of depression
refer to the definitions according to the DSM-IV. As opposed to the NICE guideline, the Ger-
man and Australian and New Zealand did not explicitly recommend low-intensity treatments
like bibliotherapy, internet-based self-help or self-help groups in the short form of their recom-
mendations. In this study, a treatment was defined as guideline-adherent as follows [5, 6]: for
mildly depressed patients, active monitoring, all low-intensity interventions like bibliotherapy
[44] or internet-based self-help [45] guided by the GP and telephone-based psychotherapy
[46] provided by a licensed psychotherapist, and psychotherapy were considered adequate
treatments. For moderate depression, psychotherapy, pharmacotherapy, telephone-based psy-
chotherapy and a combination of a low-intensity treatment combined with either pharmaco-
or psychotherapy were considered guideline-adherent. For severely depressed patients, the
combination of psychotherapy and pharmacotherapy in an in- or outpatient setting was
defined as guideline-adherent. If the selected treatment was bibliotherapy the patient was
given a self-help book to work with [44]. For the internet-based self-help treatment the patient
received a link and a license for the internet program [45]. Patients with the selection of tele-
phone-based psychotherapy were given a description of the treatment including the telephone
number of the telephone psychotherapist who awaited their call [46]. For referring the patient
to colleagues for psychotherapy or psychiatric treatment or the combination of both in an out-
patient setting, the GP booked the treatment option at a certain care provider who indicated
free capacities on the online platform. Following this the GP gave the patient this care provid-
er’s phone number to arrange an appointment. For the selections of an inpatient treatment the
GP was supposed to call the responsible contact person in one of the cooperating inpatient
care facilities and organize hospitalization.
Monitoring. Depression severity was monitored systematically by the responsible care
provider (GP, psychiatrist or psychotherapist) within predefined time intervals and
procedures.
Variables and measurement
Assessment of sociodemographic data was part of the baseline questionnaire patients filled out
directly after having given informed consent. The depression diagnosis according to ICD-10
was extracted from the ICD-10-checklist in which the GP specified the severity degree. The
classification algorithm for severity is derived from the ICD-10[26]. Here symptoms of depres-
sion are subdivided into main symptoms and additional symptoms. In case of two main and
two additional symptoms the diagnosis is a mild depression. Patients with two main and three
to four additional symptoms suffer from a moderate depression. A severe depression is diag-
nosed, if patients report three main and more than four additional symptoms.
Information about the initial treatment selection was extracted from the treatment decision
checklist filled out by the GP.
We defined treatment initialization as the first treatment a patient received up to three
months after treatment selection. Initialized treatments were extracted from the monitoring
checklists filled out by care providers during monitoring appointments. If no information
about an appointment with any care provider during the first three months after treatment
decision was available, we used data from the patient questionnaire three months after study
inclusion.
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Selected and initialized treatment was compared on patient level to determine whether they
matched. If selected and carried out treatment were identical or had the same level of intensity
(i.e., bibliotherapy or internet-based self-help; pharmaco- or psychotherapy), this was defined
as “treatment selection implemented”. If a patient received a treatment of higher intensity than
the one originally selected, this was categorized as “more intensive treatment than selected”. If
a patient was treated with a less intensive intervention than the one selected or not treated at
all, this was defined as “no or less intensive intervention”. Dropouts were defined as cases for
which neither care provider data nor follow-up patient questionnaires were available.
Statistical methods
Data was analyzed descriptively by computing frequencies for categorical data and means and
standard deviations for continuous data. Patients were grouped by their initial depression sever-
ity. We conducted a multiple mixed logistic regression model with severity degree (mild vs.
moderate vs. severe), type of depression (recurrent vs. non-recurrent), status of treatment (TS
vs. TI) and all of their 2-way and 3-way interactions as fixed effects and patient as a random
effect. We performed a backward selection of the non-significant interactions. Level of signifi-
cance was set at p<0.05, two-sided. The results are represented with odds-ratios and their 95%
confidence intervals and p values. These analyses are carried out with SPSS, Version 23 (IBM
Corp., Armonk, NY, USA) or with SAS, Version 9.4 (SAS Institute Inc., Cary, NC, USA.)
Results
Sample description
N = 610 patients were included into the study (for details see [37]). During the one-year study
period, 41 patients (7%) revoked informed consent due to having found a psychotherapist out-
side the network or not wishing to fill out any more questionnaires. Therefore, a sample of
n = 569 patients was analyzed.
Table 1 shows the baseline characteristics of the analyzed sample. According to the PHQ-9,
patients reported moderately severe depressive symptoms on average (M = 15.3; SD = 4.7).
98.9% of patients received a specific ICD-10 diagnosis from their GP. More than half (52%) of
the patients were diagnosed with a recurrent depression. Ten patients were screened positively
according to the PHQ-9 (�5 points), but their symptoms were not sufficient to receive an
ICD-diagnosis. These patients with subthreshold depression were included into the category
of mild depression.
Treatment selection, initialized treatments and guideline adherence
Table 2 displays the results of the analyses regarding initial treatment selection and initialized
treatments (research question 1).
Numbers in columns “TS” show the percentage of patients who selected the respective
treatment in the treatment decision process. Numbers in columns “TI” reflect the percentage
of patients for whom the respective treatment was initialized afterwards. These numbers were
assessed independently from which treatment was selected before, thus numbers do not allow
to conclude which proportion of selected treatments were actually implemented by simple
subtraction. For about two thirds of the 85 patients suffering frommild depression, bibliother-
apy was the most frequently selected treatment (40.0%). It was also the most frequently carried
out (38.8%), followed by internet-based self-help (20.0% and 18.8%, respectively). Treatments
of higher intensity (psychotherapy, pharmacotherapy, a combination of both) were selected in
6.0% of patients with mild depression and initialized in 7.2%. One patient (1.2%) received no
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treatment, while no further data was available for 8 patients (9.4%) with mild depression. In
sum, the rate of guideline-adherent treatment selection was 91% and the rate of guideline-
adherent treatment initialization was 85% for patients with mild depression.
Inmoderately depressed patients, the most frequent treatment selected was outpatient psy-
chotherapy (40.2%). It was carried out as an initial treatment in 26.7% of this patient group.
Pharmacotherapy was selected for 14.9% of moderately depressed patients and 15.9% received
it. Inpatient treatment was selected for 3 patients (1.0%), but none received this intervention.
Telephone-based psychotherapy was selected as initial treatment in 4.1% and actually carried
out in 2.7% of moderate depression cases. In sum, 68% of initial treatment selections and 54%
of initialized treatments are considered to be guideline-adherent for patients with moderate
depression.
Table 1. Baseline characteristics of the analyzed sample (n = 569).
M (SD) / n (%) missing data n (%)
age (years) 42.08 (13.46) 1 (0.2%)
sex (female) 412 (72.4%) 0
nationality 55 (9.7%)
German 476 (83.7%)
other European 27 (4.7%)
non-European 11 (1.9%)
currently living in a relationship 308 (54.1%) 53 (9.3%)
education 60 (10.5%)
no studies 12 (2.1%)
secondary general schoola 116 (20.4%)
intermediate secondary schoolb 157 (27.6%)
university entrance diplomac 143 (25.1%)
university degree 81 (14.2%)
current work situation 61 (10.7%)
unemployed 148 (26.0%)
part-time employment 124 (21.8%)
full-time employment 236 (41.5%)
depression severity (PHQ-9) 15.29 (4.68) 0
health-related quality of life (SF-12) 69 (12.1%)
psychological scale 28.41 (8.33)
physical scale 44.64 (10.59)
chronic disease present 234 (41.1%) 44 (7.7%)
diffuse somatic impairments present 516 (90.5%) 40 (7%)
depression diagnosis according to ICD-10 6 (1.1%)
subthreshold depression 10 (1.8%)
mild depression 75 (13.2%)
proportion recurrent 47 (8.3%)
moderate depression 296 (52.0%)
proportion recurrent 149 (26.2%)
severe depression 182 (32.0%)
proportion recurrent 105 (18.5%)
aGerman: Hauptschule (9 years of education)
bGerman: Realschule (10 years)
cGerman: Fachhochschulreife (12 years) or Gymnasium (12 to 13 years).
https://doi.org/10.1371/journal.pone.0208882.t001
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For severely depressed patients, in more than half of the cases (59.3%) the selected treatment
was a combination of psycho- and pharmacotherapy as advised by the guidelines, followed by
stand-alone outpatient psychotherapy (21.4%). However, initialization of combined psycho-
and pharmacotherapy often did not take place: only 18.6% of severely depressed patients actu-
ally received this combination. In accordance with the guidelines, low-intensity interventions
were seldom chosen (3.2%) and rarely applied (6.0%). In 6.0% of the cases, an inpatient setting
was selected, but only 0.5% (1 patient) actually received it. Pharmacotherapy as a stand-alone
treatment was the most frequently applied treatment in patients with severe depression
(25.3%). None of the severely depressed patients remained without any active treatment (with
the exception of dropouts, see next paragraph). In sum, 59% of initial treatment selections and
19% of initialized treatments can be considered guideline-adherent for patients with severe
depression.
Patients from all three severity levels had comparable dropout rates of approximately 10%.
The proportion of patients whose initial treatment was a further GP consultation without any
specific intervention was also about 11% in all groups.
Summing up the proportions of guideline adherence for the total sample, treatment selec-
tions were guideline-adherent in 68% of the cases, and treatments actually initialized were
guideline-adherent in 47% of the cases.
The multiple mixed logistic regression revealed a significant interaction between status of
treatment (TS vs. TI) and severity degree (mild vs. moderate vs. severe).
Table 3 shows that for patients suffering from moderate depression, the odds of obtaining a
guideline adherent treatment selection were 1.8 times higher than for guideline adherence in
treatment initialization [95% CI: 1.30 to 2.59; p = 0.0006]. For severely depressed patients the
odds for a guideline adherent treatment selection were 6.9 times higher than for guideline
adherent treatment initialization [95% CI: 4.24 to 11.25; p< .0001]. Accordingly the difference
in guideline adherence between treatment selection and initialization is significant for moder-
ate depression as well as for severe depression but not for mild depression (OR = 1.8, [95%-CI:
0.68 to 4.56; p = 0.2426]). Furthermore, there was no difference in guideline adherent treat-
ment rates between patients with a recurrent depression and those with a first occurrence of
Table 2. Initial treatment selection (TS) and actual treatment initialization (TI) in %.
Treatment Level of depression severity total (N = 569)
mild (n = 85) moderate (n = 296) severe (n = 182)
TS TI TS TI TS TI TS TI
active monitoring/GP consultation 15.3 11.8 5.1 11.5 2.7 12.1 5.8 11.6
bibliotherapy 40.0 38.8 7.4 7.4 1.6 2.2 10.4 10.4
internet-based self-help 20.0 18.8 7.1 7.8 0.5 1.6 6.9 7.4
telephone-based psychotherapy 10.6 7.1 4.1 2.7 1.1 2.2 4 3.3
psychotherapy 2.4 2.4 40.2 26.7 21.4 22.5 28.3 21.6
pharmacotherapy 1.2 2.4 14.9 15.9 5.5 25.3 9.7 16.9
combined psycho- & pharmaco-therapy 2.4 2.4 6.1 6.8 53.3 18.1 20.6 9.8
other combination 2.4 5.9 8.4 8.8 3.7 5.5 6 7.2
inpatient treatment 0.0 0.0 1 0.0 6 0.5 2.5 0.2
no intervention 0.0 1.2 0.0 2.0 0.0 0.0 0.0 1.2
missing treatment decision 5.9 - 5.7 - 3.8 0.0 6 0.0
dropout 0.0 9.4 0.0 10.5 0.0 9.9 0.0 10.4
Proportion of guideline adherence 91% 85% 68% 54% 59% 19% 68% 47%
Bold numbers mark guideline-adherent treatment selection and initialization for the specific severity degree.
https://doi.org/10.1371/journal.pone.0208882.t002
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depression (OR = 1.1, [95%-CI: 0.81 to 1.50; p = 0.5500]). This effect is the same at treatment
selection and treatment initialization.
Accordance between selected and initialized treatments
Results for research question 2 underline that the selection of a particular treatment does not auto-
matically lead to its initialization. Fig 1 illustrates the differences between which treatment was
selected and which treatment was actually initialized on a patient level. Almost three quarters
(72%) of patients withmild depression received either the treatment originally decided upon or an
equally intensive treatment. Nine patients (11%) received a more intensive treatment than
planned and 4 (5%) received a less intensive treatment or no intervention at all. Patients suffering
frommoderate depression received the selected treatment in almost two thirds of cases. The rate of
patients who received less intensive treatment than scheduled or none (38 patients; 13%) was
somewhat higher for this group than for the group of patients with mild depression. Of patients
with severe depression, approximately 45% received the planned treatment while nearly the same
proportion of patients (43%) received a less intensive treatment than planned. However, as shown
in Table 2, no patient with severe depression remained without any treatment.
Discussion
We described results regarding guideline-adherent treatment selection and initialization for a
sample of n = 569 patients within a stepped and collaborative care model (SCM) in routine
care. The SCM aimed to optimize diagnostic procedures, treatment decision processes and
implementation of guideline-based interventions. To evaluate whether this sample is represen-
tative for the German population of persons suffering from depression two studies are avail-
able. The distribution of gender in the sample seems to be comparable with twice as many
female than male depression patients [14]. Regarding marital status we found comparable data
with 54% currently living in a relationship in our study in comparison to 60% in another large
epidemiological health care study and for chronic somatic conditions (41% vs. 47%) in the
same study [47]. Concerning the distribution of severity degrees in depression a comparison is
difficult, as one of the studies [14] revealed that in routine care 50% of the depression diagno-
ses are unspecific and thus do not allow a statement about the degree of severity of the depres-
sion. In our study almost every patient (98.9%) received a specific ICD-10 diagnosis. As we did
not collect data of the diagnostic process and the specific diagnoses in the control group we
cannot draw a direct comparison between CG and IG. However, we know from a big external
administrative study that only half of the registered depression diagnoses are specific, while
50% remain unspecific [14]. This demonstrates that procedures such as training as well as
symptom checklists can substantially increase the specificity of GP diagnoses.
Guideline adherence regarding initial treatment selections
The results regarding treatment selection mostly show a high guideline adherence. This prom-
ising result may be attributed to the specific training in guideline recommendations and
Table 3. Guideline adherence in treatment selection (TS) and initialization (TI).
Difference in guideline adherence referring to treatment selection and treatment initialization
Severity degree TS TI TS vs TI
n % n % OR 95% CI p
Mild 77 91 72 85 1.762 0.68–4.56 0.2426
Moderate 200 68 160 54 1.836 1.30–2.59 0.0006
Severe 108 59 34 19 6.903 4.24–11.25 < .0001
https://doi.org/10.1371/journal.pone.0208882.t003
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shared decision-making processes. The implementation of supporting tools such as the treat-
ment decision checklists for GPs probably contributed as well. To our knowledge, no other
studies report data on treatment selection or differentiate between selected and initialized
treatments as we did. One partially comparable study analyzed the management of depression
in UK general practices in relation to severity degree and reported lower rates of guideline-
adherent treatment decisions [27]: 49% of mildly depressed patients were prescribed an anti-
depressant and only few patients with moderate to severe depression were referred to psycho-
logical or psychiatric services (1.6% resp. 5.6%)–results which are not in accordance with the
guidelines. In our study, the rate of guideline-adherent treatment selection was highest for
patients with mild depression, where antidepressant prescriptions were almost nonexistent
and low-intensity treatments were selected frequently. Bibliotherapy was selected and initial-
ized approximately twice as frequently as internet-based self-help and four times as often as
Fig 1. Implementation of treatment decisions. green: treatment decision implemented; orange: treatment
implemented more intensive then the selected treatment; red: no or less intensive treatment implemented then the
selected treatment; grey: missing treatment decision; white: dropout.
https://doi.org/10.1371/journal.pone.0208882.g001
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telephone-based therapy. One reason for this finding could be, that the book for the bibliother-
apy could be handed out immediately while the access to the internet-based self-help (lock-in
with a license code) or to the telephone-based therapy (calling the telephone psychotherapist)
was less immediate. Another reason could be, that working with a book or a companion is
more known and intimate than working with internet-based self-help or telephone based ther-
apy. Treatment selection was less guideline-adherent for moderate and severe depression. For
moderately depressed patients, psychotherapy was selected almost three times as often as phar-
macotherapy, even though the guideline recommends offering the patient psychotherapy and
antidepressants as equivalent treatments. This is in agreement with the results of an American
primary care survey finding that two thirds of patients preferred counseling over antidepres-
sant treatment [48, 49]. Patient preferences may have been one cause for selecting treatments
that were not guideline-adherent: While guidelines place great importance on severity degree,
they also explicitly state that patient preferences and characteristics should be taken into
consideration.
Guideline adherence regarding applied first treatments
The overall proportion of 47% of guideline-adherent initialized treatments in this SCM is
twice as high as in primary care, according to a European study reporting that only 23% of
patients with anxiety and depression received an adequate treatment [11]. This shows the
potential of specific SCMs; however, there is still room for further improvement.
With approximately 11%, the proportion of patients receiving a further GP-consultation as
first treatment was similar in each of the three severity groups. For some of these patients,
active monitoring had actually been scheduled. The others may have consulted their GP due to
failed initialization of the originally selected treatments. The rate of patients who dropped out
in the sense of not returning to the GP or any other care provider of the network and not
answering any follow-up questionnaire was also comparable over all severity groups. For these
approximately 10% of patients, it is also likely that the initialization of the selected treatment
failed. However, in routine care attrition rates are usually much higher than those found in
our study [14] and even in comparison to other SCMs this rate of probably untreated patients
is low. Another implementation study of four SCMs in routine care found attrition rates of
about 30% [33].
For mildly depressed patients, guideline adherence in treatment initialization was high:
there was a very low rate of misapplication of antidepressants in comparison to routine care
[14, 27]. Even compared to other stepped-care models, only 5% oversupply with antidepres-
sants is remarkably low. Gidding and colleagues [50] reported almost 30% of non-severely
depressed patients being treated with antidepressants. Additionally, only 16% of non-severely
depressed patients received minimal interventions (comparable to low-intensity treatments in
our SCM), compared to 73% of mildly depressed patients in our study [50]. This indicates that
the SCM’s concept of referring patients with mild depression into low-intensity interventions
as a first step and thus reserving more intensive treatments for patients with more severe disor-
ders was successfully implemented. It also reflects substantial acceptance of these interven-
tions, as well as their high and prompt availability and practicality. These results are confirmed
by another study showing a high acceptance of all three low-intensity interventions from the
perspective of the care providers [42].
Moderately depressed patients received less guideline-adherent interventions than mildly
depressed patients, but almost three times higher rates of adequate treatments than severely
depressed patients. A considerable proportion of moderately depressed patients were not sup-
plied with psychotherapy as planned, indicating that this may be a crucial aspect of impeded
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treatment initializations. Possible reasons for this finding will be discussed in paragraph
“Potential barriers and resources for guideline-adherent care”.
For severely depressed patients, the guideline adherence of initialized treatments was low,
the majority of patients received a first treatment of insufficient intensity. However, all patients
received some form of active treatment, while 18% of severely depressed patients received no
treatment at all in a routine care study [14]. A comparable SCM study [51] reported that 57%
of severely depressed patients received adequate treatments. But these different results are dif-
ficult to interpret as the group of severely depressed patients in this study consists of moder-
ately and severely depressed patients opposed to severely depressed patients only in our study.
Further on there are different definitions of “adequate treatment”: In our study, severe depres-
sion was supposed to be treated with a combination of psycho- and pharmacotherapy in line
with NICE guideline [5]. In contrast, in Franx and colleagues’ [51] SCM, either psycho- or
pharmacotherapy was considered to be a sufficient treatment to start with for severely
depressed patients. If we had defined stand-alone psycho- and pharmacotherapy as adequate
treatments for severe depression, our SCM would have achieved a rate of 66% of adequately
treated severely depressed patients.
Our results indicate that the lower the severity degree is, the higher the probability to
receive adequate treatment is. This is also underlined by the result that confirms the significant
difference between guideline-adherent treatment selection and initialization for different
severity degrees. This finding corresponds to Franx and colleagues’ [51] stepped care study, in
which care provision was found to improve for non-severely depressed patients, but not to the
same degree as in patients with severe depression.
Differentiation between selection and initialization
To our knowledge, this is the first study which differentiates between treatment selection and
actual treatment initialization in depression care. Our results demonstrate the gap which exists
between treatment selection and actual implementation as well as the interaction between
“treatment selection/treatment initialization” and “severity degree of depression”. We found
that it is by far not enough to improve care providers’ awareness of guideline recommenda-
tions. Unfortunately, even when treatments are correctly selected, they are often not imple-
mented afterwards, especially in cases of severe depression.
Potential barriers and resources for guideline-adherent care
Failure to initialize a treatment may be caused by different barriers impeding the delivery of
adequate interventions. Limited access to adequate care for depression is described as a major
barrier by different authors. These can be care provider-related barriers such as insufficient
knowledge regarding diagnostics and mental disorders in a primary care setting; factors
related to the health care system in general such as insufficiently available and integrated
resources or long waiting times for therapy; and patient-related aspects such as fear of stigma-
tization, time constraints or cultural factors [28, 52, 53].
In the SCM, the barrier of insufficient care provider knowledge regarding diagnostics and
psychological disorders was addressed by training providers and enhancing professional
exchange between psychotherapists, psychiatrists and GPs in regular quality circles. The fact
that a greater amount of specific depression diagnoses were made in our study than in routine
care shows that we were successful at improving care providers’ knowledge about depression.
Additionally, the knowledge about evidence-based and adequate interventions improved, as
indicated by the relatively high rate of guideline-adherent treatment selections. In order to
overcome barriers related to the health care system in general, we established a care provider
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network to provide sufficient treatment capacities. We also developed and implemented an
online platform to enhance the referral process (cp. section Multi-professional network). This
online platform was used frequently and appreciated by the care providers [42]; however,
these measures may still have been insufficient to pave the way from GP to secondary care pro-
vider in a relevant proportion of cases. Especially initializing a combination of psycho- and
pharmacotherapy for patients with severe depression may have been encumbered by an inter-
face problem. Two or even three care providers may be involved in this complex intervention
and there may have been difficulties in the referral processes or the patient’s transition from
one care provider to another. Another reason may have been a lack of available psychotherapy
resources despite their generally higher availability within the SCM compared to routine care.
This could be an explanation for the gap between selected and applied stand-alone psychother-
apy in moderately depressed patients as well. A further reason for the insufficient initialization
of combined psycho- and pharmacotherapy for patients with severe depression might have
been that their higher symptom burden affected treatment implementation. For example, for a
severely depressed patient, the challenge to call a psychotherapist for an appointment may be
higher than for a mildly depressed patient whose symptoms of social withdrawal and hopeless-
ness are lower. Patients in severe crises might also be more ambivalent towards treatments and
decide against a selected treatment before even beginning it, duo to doubts and negative emo-
tions. To address patient-related constraints like these, GPs were supported by psycho-educa-
tional materials explaining the nature of depression, symptoms and treatment options,
amongst others. For patients with time constraints, interventions with high availability, flexi-
bility and practicality were offered, which were meant to be easy to integrate into daily life.
Low-intensity treatments can be applied independently of specific appointments and mobility
aspects.
One limitation of this study is the lack of validation of the ICD-diagnoses made by the GPs,
as no “gold standard” (e.g. structured diagnostic interviews) was additionally applied. This was
not possible in the present study due to organizational limitations. The specificity of the diag-
noses may have been partially “forced” by the structure of the symptom checklist used. How-
ever, GPs perceived the checklist to be a helpful tool for the diagnostic process [42]. Criteria
for defining selection and initialization of an intervention as guideline-adherent were based
only on the criterion of severity degree. Although severity is one central criterion for guide-
line-based treatment decisions in depression, the guideline stresses patient preferences as a fur-
ther important criterion. As data about patients’ preferences (and about the interaction
between patient and GP during the treatment decision process) were not collected, we do not
know which treatment decisions and initializations were based on this latter criterion.
Strengths of this study are the large sample size of primary care patients and its assessment
of information about the crucial phase of treatment initialization, differentiated into treatment
selection and actual treatment initialization. We investigated this under routine care condi-
tions and for different subgroups of depressed patients.
Conclusion
Several important conclusions can be drawn from this study. First of all, SCMs are feasible and
capable of improving diagnostic processes, treatment selection, adequate treatment of mildly
depressed patients and application of low-intensity interventions in depression care. Further-
more, this study described the important difference of treatment selection and treatment ini-
tialization regarding guideline-adherence. Rates of guideline-adherent treatments varied
between patient groups of different depression severities. The low rate of guideline-adherent
first treatments in severely depressed patients was not primarily a problem of inadequate
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treatment selection or lack of knowledge, but rather a matter of failed implementation. Further
studies should examine which elements of the treatment initialization and implementation
process cause difficulties, such as a lack of treatment availability or problems during referral
from one care provider to another. Additionally, it will be important to further investigate
which barriers and enablers on the level of care provider, health care system and patient char-
acteristics are related to successful implementation, such as patients’ disease course or physical
and mental health condition.
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